CareRx Statistics
Total Valuation
CareRx has a market cap or net worth of CAD 204.18 million. The enterprise value is 271.14 million.
| Market Cap | 204.18M |
| Enterprise Value | 271.14M |
Important Dates
The last earnings date was Wednesday, November 4, 2026.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Dec 14, 2026 |
Share Statistics
CareRx has 63.41 million shares outstanding. The number of shares has increased by 1.61% in one year.
| Current Share Class | 63.41M |
| Shares Outstanding | 63.41M |
| Shares Change (YoY) | +1.61% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 1.55% |
| Owned by Institutions (%) | 25.81% |
| Float | 34.10M |
Valuation Ratios
The trailing PE ratio is 8.08 and the forward PE ratio is 12.50.
| PE Ratio | 8.08 |
| Forward PE | 12.50 |
| PS Ratio | 0.54 |
| PB Ratio | 1.88 |
| P/TBV Ratio | 21.41 |
| P/FCF Ratio | 10.55 |
| P/OCF Ratio | 7.65 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.15, with an EV/FCF ratio of 14.00.
| EV / Earnings | 10.61 |
| EV / Sales | 0.72 |
| EV / EBITDA | 10.15 |
| EV / EBIT | 22.68 |
| EV / FCF | 14.00 |
Financial Position
The company has a current ratio of 1.15, with a Debt / Equity ratio of 0.72.
| Current Ratio | 1.15 |
| Quick Ratio | 0.77 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 2.91 |
| Debt / FCF | 4.01 |
| Interest Coverage | 1.99 |
Financial Efficiency
Return on equity (ROE) is 26.12% and return on invested capital (ROIC) is 6.80%.
| Return on Equity (ROE) | 26.12% |
| Return on Assets (ROA) | 3.20% |
| Return on Invested Capital (ROIC) | 6.80% |
| Return on Capital Employed (ROCE) | 6.49% |
| Weighted Average Cost of Capital (WACC) | 6.90% |
| Revenue Per Employee | 255,465 |
| Profits Per Employee | 17,237 |
| Employee Count | 1,533 |
| Asset Turnover | 1.62 |
| Inventory Turnover | 14.22 |
Taxes
| Income Tax | -21.57M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.20% in the last 52 weeks. The beta is 0.54, so CareRx's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | -7.20% |
| 50-Day Moving Average | 3.24 |
| 200-Day Moving Average | 3.46 |
| Relative Strength Index (RSI) | 48.41 |
| Average Volume (20 Days) | 53,379 |
Short Selling Information
The latest short interest is 865, so 0.00% of the outstanding shares have been sold short.
| Short Interest | 865 |
| Short Previous Month | 1,548 |
| Short % of Shares Out | 0.00% |
| Short % of Float | 0.00% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CareRx had revenue of CAD 378.86 million and earned 25.56 million in profits. Earnings per share was 0.40.
| Revenue | 378.86M |
| Gross Profit | 112.68M |
| Operating Income | 11.96M |
| Pretax Income | 4.00M |
| Net Income | 25.56M |
| EBITDA | 22.60M |
| EBIT | 11.96M |
| Earnings Per Share (EPS) | 0.40 |
Balance Sheet
The company has 10.66 million in cash and 77.62 million in debt, with a net cash position of -66.96 million or -1.06 per share.
| Cash & Cash Equivalents | 10.66M |
| Total Debt | 77.62M |
| Net Cash | -66.96M |
| Net Cash Per Share | -1.06 |
| Equity (Book Value) | 108.43M |
| Book Value Per Share | 1.71 |
| Working Capital | 8.76M |
Cash Flow
In the last 12 months, operating cash flow was 26.67 million and capital expenditures -7.31 million, giving a free cash flow of 19.36 million.
| Operating Cash Flow | 26.67M |
| Capital Expenditures | -7.31M |
| Depreciation & Amortization | 10.65M |
| Net Borrowing | -10.61M |
| Free Cash Flow | 19.36M |
| FCF Per Share | 0.31 |
Margins
Gross margin is 29.74%, with operating and profit margins of 3.16% and 6.75%.
| Gross Margin | 29.74% |
| Operating Margin | 3.16% |
| Pretax Margin | 1.05% |
| Profit Margin | 6.75% |
| EBITDA Margin | 5.97% |
| EBIT Margin | 3.16% |
| FCF Margin | 5.11% |
Dividends & Yields
This stock pays an annual dividend of 0.09, which amounts to a dividend yield of 2.73%.
| Dividend Per Share | 0.09 |
| Dividend Yield | 2.73% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 14.81% |
| FCF Payout Ratio | 27.51% |
| Buyback Yield | -1.61% |
| Shareholder Yield | 1.12% |
| Earnings Yield | 12.38% |
| FCF Yield | 9.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for CareRx is 4.93, which is 53.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 4.93 |
| Price Target Difference | 53.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 4.31% |
| EPS Growth Forecast (3Y) | 115.27% |
Stock Splits
The last stock split was on June 25, 2020. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jun 25, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
CareRx has an Altman Z-Score of 1.23 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.23 |
| Piotroski F-Score | 6 |